Resa Schlossberg - MergerLinks

AcquisitionMajorityPublicDomestic

target

Kite Pharma

bidder

Gilead Sciences

£9,302m

24 dealmakers

Private EquityAcquisitionPrivate

Medical Equipment

target

Omni Orthopaedics

bidder

Corin Group

value n/a

13 dealmakers

PrivateAcquisitionPrivate EquityPrivate Equity

Consumer Lending

target

Lendmark Financial Services

bidder

Lightyear Capital

value n/a

33 dealmakers

AcquisitionPrivatePrivate Equity

Clothing and Accessories

target

REFORMATION

bidder

Permira Advisers

value n/a

12 dealmakers

AcquisitionPrivate EquityPublic

target

Cambrex Corporation

bidder

Permira Advisers

£1,972m

34 dealmakers

AcquisitionPrivate

target

Semma Therapeutics

bidder

Vertex Pharmaceuticals

£785m

26 dealmakers

Knowledge Process Outsourcing

Private EquityAcquisitionPrivate

target

AXIOM

bidder

Permira Advisers

value n/a

13 dealmakers

Farming Fishing Ranching and Plantations

Spin OffMajorityPublicPrivate Equity

target

Corteva

bidder

Institutional Investors

£16,649m

16 dealmakers

AcquisitionMajorityPublic

target

Achillion Pharmaceuticals

bidder

Alexion Pharmaceuticals

£732m

21 dealmakers

Cross BorderPublicAcquisitionMajority

Semiconductors

target

Kemet Corporation

bidder

Yageo Corporation

£1,276m

50 dealmakers

Cross BorderAcquisitionMajorityPublicTender Offer

target

Arqule

bidder

Merck Kgaa

£2,054m

62 dealmakers

PublicAcquisitionMergerMajorityDisposalDomestic

Food Products

target

Dupont (nutrition & Biosciences Business)

bidder

International Flavors & Fragrances

£19,638m

49 dealmakers

Knowledge Process Outsourcing

PrivateMajorityAcquisitionPrivate EquityDomestic

target

Bliss Lawyers

bidder

Permira Advisers

value n/a

17 dealmakers

AcquisitionPublicMajorityTender Offer

target

Forty Seven

bidder

Gilead Sciences

£3,821m

48 dealmakers

Oil Equipment and Services

MajorityMergerPublicAcquisitionDomestic

target

Quintana Energy Services

bidder

Klx Energy Services Holdings

value n/a

38 dealmakers

PublicAcquisitionMajorityDisposalCross Border

target

Stemline Therapeutics

bidder

Menarini Group

£541m

44 dealmakers

PrivateMajorityAcquisitionPrivate EquityCross Border

target

Cersci Therapeutics

bidder

Acadia Pharmaceuticals

£717m

20 dealmakers

DomesticMajorityAcquisitionPublic

target

Biospecifics Technologies Corp

bidder

Endo Pharmaceuticals

£487m

26 dealmakers

AcquisitionMergerPrivateMajorityDomesticDe-SPACReverse Takeover

target

Celularity

bidder

Gx Acquisition Corp

£920m

52 dealmakers

AcquisitionPublicDomesticMajorityTender Offer

target

Pandion Therapeutics

bidder

Merck & Co

£1,308m

28 dealmakers

PublicMajorityAcquisitionDomestic

target

STRONGBRIDGE

bidder

Xeris Pharmaceuticals

£188m

53 dealmakers

DomesticMajorityMergerAcquisitionPublic

Software

target

Aspen Technology

bidder

Emerson Electric Co

£8,081m

49 dealmakers

MajorityPrivate EquityPrivateAcquisitionDomestic

target

Lyophilization Services Of New England

bidder

Pci Pharma Services

value n/a

52 dealmakers

DomesticPrivateAcquisitionMajorityReverse TakeoverDe-SPACMerger

Entertainment

target

Faze Clan

bidder

B. Riley Financial

£717m

52 dealmakers

MajorityCross BorderAcquisitionPublic

target

DICERNA

bidder

Novo Nordisk

£2,452m

23 dealmakers

PublicAcquisitionDomesticMajority

target

Antares Pharma

bidder

HALOZYME

£737m

59 dealmakers

AcquisitionCross BorderPublicPrivate EquityMinority

target

Vtv Therapeutics

bidder

G42

£20m

5 dealmakers

MajorityDomesticAcquisitionPrivate

target

VIACYTE

bidder

Vertex Pharmaceuticals

£265m

42 dealmakers

MergerAcquisitionMajorityCross BorderPublic

target

Aerie Pharmaceuticals

bidder

Alcon

£650m

58 dealmakers

MinorityPrivate EquityDomesticPrivateAcquisition

Construction Services

target

Gannett Fleming

bidder

Oceansound Partners

value n/a

14 dealmakers

AcquisitionMajorityPrivatePrivate EquityDomestic

Software

target

NXTSOFT

bidder

Oceansound Partners

value n/a

18 dealmakers

United StatesUnited States

Software

MajorityAcquisitionDomesticPrivate EquityPrivate

target

IMM

bidder

CFM

value n/a

14 dealmakers

Canada

AcquisitionCross BorderMajorityPublic

target

Bellus Health

bidder

Glaxosmithkline

£1,614m

17 dealmakers

Cross BorderMajorityPublicAcquisition

target

Iveric Bio

bidder

Astellas Pharma

£4,693m

22 dealmakers

Private EquityMajorityDomesticAcquisitionPrivate

Medical Equipment

target

Spectrum Plastics Group

bidder

DUPONT

£1,397m

41 dealmakers

AcquisitionDomesticMajorityPrivatePrivate Equity

Specialty Chemicals

target

Dupont (delrin Business)

bidder

Tjc (the Jordan Company)

£1,412m

70 dealmakers

AcquisitionMajorityCross BorderPublic

target

Intercept Pharmaceuticals

bidder

Alfasigma

£649m

31 dealmakers

DomesticAcquisitionMajorityPublic

target

Point Biopharma

bidder

Eli Lilly And Company

£1,152m

40 dealmakers

MajorityDomesticPublicAcquisition

target

Mirati Therapeutics

bidder

Bristol Myers Squibb Company

£3,840m

54 dealmakers

Canada

Specialty Chemicals

AcquisitionMajorityPrivateCross Border

target

Lucas Meyer Cosmetics

bidder

Clariant

£667m

41 dealmakers

AcquisitionDomesticMajorityPrivate

Electrical Components

target

Carrier (global Access Solutions Business)

bidder

Honeywell International

£3,937m

83 dealmakers

AcquisitionDomesticMajorityPublic

target

Ambrx

bidder

Johnson & Johnson

£1,493m

38 dealmakers

Germany

AcquisitionCross BorderPublicMajority

target

Morphosys

bidder

Novartis

£2,309m

93 dealmakers